Trade Champions Oncology, Inc. - CSBR CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
|
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 5.03 |
| Open | 5.02 |
| 1-Year Change | 1.83% |
| Day's Range | 4.99 - 5.02 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 26, 2024 | 4.99 | -0.03 | -0.60% | 5.02 | 5.02 | 4.99 |
| Apr 25, 2024 | 5.03 | -0.09 | -1.76% | 5.12 | 5.12 | 4.82 |
| Apr 24, 2024 | 5.03 | -0.01 | -0.20% | 5.04 | 5.04 | 5.03 |
| Apr 23, 2024 | 5.09 | 0.02 | 0.39% | 5.07 | 5.09 | 4.82 |
| Apr 22, 2024 | 5.02 | 0.20 | 4.15% | 4.82 | 5.03 | 4.82 |
| Apr 19, 2024 | 5.03 | 0.21 | 4.36% | 4.82 | 5.03 | 4.82 |
| Apr 18, 2024 | 5.02 | 0.20 | 4.15% | 4.82 | 5.03 | 4.82 |
| Apr 17, 2024 | 5.02 | 0.19 | 3.93% | 4.83 | 5.05 | 4.83 |
| Apr 16, 2024 | 5.09 | 0.27 | 5.60% | 4.82 | 5.09 | 4.82 |
| Apr 15, 2024 | 5.01 | 0.01 | 0.20% | 5.00 | 5.01 | 4.89 |
| Apr 12, 2024 | 4.94 | 0.18 | 3.78% | 4.76 | 5.08 | 4.74 |
| Apr 11, 2024 | 4.89 | -0.02 | -0.41% | 4.91 | 4.91 | 4.89 |
| Apr 10, 2024 | 4.87 | -0.08 | -1.62% | 4.95 | 4.95 | 4.74 |
| Apr 9, 2024 | 4.96 | 0.00 | 0.00% | 4.96 | 4.96 | 4.96 |
| Apr 8, 2024 | 4.97 | 0.20 | 4.19% | 4.77 | 4.98 | 4.74 |
| Apr 5, 2024 | 4.85 | 0.08 | 1.68% | 4.77 | 4.85 | 4.77 |
| Apr 4, 2024 | 4.77 | 0.00 | 0.00% | 4.77 | 4.77 | 4.77 |
| Apr 3, 2024 | 4.77 | 0.00 | 0.00% | 4.77 | 4.77 | 4.77 |
| Apr 2, 2024 | 4.82 | 0.05 | 1.05% | 4.77 | 4.84 | 4.77 |
| Apr 1, 2024 | 4.89 | 0.15 | 3.16% | 4.74 | 4.89 | 4.74 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Champions Oncology, Inc. Company profile
About Champions Oncology Inc
Champions Oncology, Inc. is engaged in creating transformative technology solutions to be utilized in oncology drug discovery and development. This technology includes the Company’s in-vivo, ex-vivo and biomarker platforms, oncology software solutions, and computational-based discovery platforms. The Company’s TumorGraft Technology Platform (The Platform) provides select services to pharmaceutical and biotechnology. The Company’s software as a service business is centered around its software platform and data tool, Lumin Bioinformatics (Lumin), which contains comprehensive information derived from its research services and clinical studies. The Company’s drug discovery and development business leverages the computational and experimental capabilities within its platforms. Their discovery strategy utilizes its datacenter, coupled with artificial intelligence and other advanced computational analytics, to identify novel therapeutic targets.
Financial summary
BRIEF: For the nine months ended 31 January 2022, Champions Oncology Inc revenues increased 19% to $36.2M. Net income decreased 14% to $892K. Revenues reflect Pharmacology services segment increase of 66% to $34.5M, Other segment increase from $101K to $1.7M. Net income was offset by research and development increase of 32% to $6.8M (expense), general and administratiojn increase of 32% to $5.9M (expense).
Equity composition
Common Stock $.001 Par, 01/11, 50M auth., 36,853,000 issd. less 1,236,000 shs. in Treas. @ $292K. Insiders & strategic holders own 64.79%. Public Offering 9/85, 40M Units (1 sh. com. + 3 warrants) @ $.01 by the Company. 02/07, Name changedfrom Champions Sports Inc.08/15, 1-for-12 Reverse stock split.
| Industry: | Biotechnology & Medical Research (NEC) |
Suite 619
855 N. Wolfe Street
BALTIMORE
MARYLAND 21205
US
News
We’re partnering with Newsquawk
Filter out the noise and focus on the news that matters.
08:32, 23 April 2024
US Earnings Season: Tesla, Alphabet, Meta Platforms and Microsoft
The first lot of Wall Street’s mega-cap tech companies report in the coming week. We preview what to expect from Tesla, Alphabet, Meta, and Microsoft’s quarterly results.
15:56, 22 April 2024
Gold price in 2024: geopolitical tensions and rate-cut expectations keep XAU/USD supported
Investors are keeping a close eye on gold as the conflict in the Middle East escalates with a possibility of a full-scale regional war in the area.
07:56, 17 April 2024
US Earnings Season : JP Morgan, Citigroup, Wells Fargo
The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.
16:03, 11 April 2024
Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues
The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
09:22, 11 April 2024
US CPI Preview: US inflation expected to grind lower amid fears about sticky prices
US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).
15:11, 9 April 2024
How escalating geopolitical tensions are impacting oil markets
The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.
13:34, 4 April 2024People also watch
Still looking for a broker you can trust?
Join the 610,000+ traders worldwide that chose to trade with Capital.com